Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/03/2012 | CN102711753A Methods and compositions for treatment of ocular fibrosis |
10/03/2012 | CN102711752A Use of bethanechol for treatment of xerostomia |
10/03/2012 | CN102711751A Pharmaceutical composition |
10/03/2012 | CN102711750A Pharmaceutical use of multicyclic compounds as anti-AIDS agents |
10/03/2012 | CN102711749A Tryptophan hydroxylase inhibitors for the treatment of cancer |
10/03/2012 | CN102711748A Pharmaceutical combination of prostaglandin compound and NSAID for the treatment of glaucoma and ocular hypertension |
10/03/2012 | CN102711747A Method for treating herpes virus infection |
10/03/2012 | CN102711746A Pharmaceutical composition for treating alcohol dependency |
10/03/2012 | CN102711745A Topical use of hydroxytyrosol and derivatives for the prevention of HIV infection |
10/03/2012 | CN102711744A Transdermal therapeutic system for administering rivastigmine or derivatives thereof |
10/03/2012 | CN102711743A Methods of making and using compositions comprising flavonoids |
10/03/2012 | CN102711741A Delivery carrier |
10/03/2012 | CN102711740A Sustained release tablet containing theobromine |
10/03/2012 | CN102711738A Reduced mass metformin formulations |
10/03/2012 | CN102711737A Oral preparation having improved quality |
10/03/2012 | CN102711736A Pharmaceutical compositions comprising sigma receptor ligands |
10/03/2012 | CN102711735A Capsules of active pharmaceutical ingredients and polyunsaturated fatty acid esters for the treatment of cardiovascular diseases |
10/03/2012 | CN102711732A Cosmetic foam |
10/03/2012 | CN102711731A Composition comprising bioactive amino acids and/or peptides and marine oil in a stable oil-in-water emulsion, and the use of said composition as a functional or therapeutic composition |
10/03/2012 | CN102711730A Methods for internally controlling or treating equine bot larvae |
10/03/2012 | CN102711729A Topical gels |
10/03/2012 | CN102711726A Method and composition for preparing stable liquid formulations of paracetamol |
10/03/2012 | CN102711722A Polysaccharide gel formulation having multi-stage bioactive agent delivery |
10/03/2012 | CN102711720A Prophylactic or ameliorating agent fo pigmentation |
10/03/2012 | CN102711709A Devices, methods, and composition for controlling infections |
10/03/2012 | CN102711525A Nutritional emulsions comprising calcium HMB and soluble protein |
10/03/2012 | CN102711524A Nutritional emulsions comprising calcium hmb |
10/03/2012 | CN102711523A Nutritional powders comprising spray dried HMB |
10/03/2012 | CN102711517A Soy protein-based nutritional formula with superior stability |
10/03/2012 | CN102711513A Compositions including pyruvate for companion animals and methods of use thereof |
10/03/2012 | CN102711481A Process for the preparation of pyrazinone thrombin inhibitor and its intermediates |
10/03/2012 | CN102711480A Topical antiparasitic formulations |
10/03/2012 | CN102711477A Synergistic fungicidal mixtures for fungal control in cereals |
10/03/2012 | CN102711475A Novel compounds and therapeutic use thereof for protein kinase inhibition |
10/03/2012 | CN102711474A Quinazoline compounds |
10/03/2012 | CN102711472A Phosphorus containing quinazoline compounds and methods of use |
10/03/2012 | CN102711470A Novel tricyclic compounds |
10/03/2012 | CN102711468A Pyrido[4,3-B]indoles and methods of use |
10/03/2012 | CN102711467A Pyrido(3,4-b)indoles and methods of use |
10/03/2012 | CN102711466A Bridged heterocyclic compounds and methods of use |
10/03/2012 | CN102711463A Hypersulfated disaccharide formulations |
10/03/2012 | CN102711461A Intermediate compounds and processes for the preparation of tapentadol and related compounds |
10/03/2012 | CN102703327A Cladosporium Sp. XJ-AC03 and application thereof |
10/03/2012 | CN102703060A Targeted tracing noble metal fluorescence probe and anti-tumor prodrug |
10/03/2012 | CN102702582A Zeamays L. polysaccharide and preparation method and application thereof |
10/03/2012 | CN102702451A High-efficiency and antibacterial polymeric micelle with high pH sensibility and biocompatibility and preparation method thereof |
10/03/2012 | CN102702382A Preparation method of chitosan derivative and application in anticoagulant drug |
10/03/2012 | CN102702377A Termitomyces albuminosus polysaccharide separation and purification method and injection thereof |
10/03/2012 | CN102702374A Method of producing polysaccharide derivatives |
10/03/2012 | CN102702303A Tanshinone derivative, medicinal composition thereof and application of tanshinone derivative to pharmacy |
10/03/2012 | CN102702302A Tanshinone class I derivant and synthesizing method and application thereof |
10/03/2012 | CN102702300A Compound for preventing or treating autoimmune diabetes and preparation method and application thereof |
10/03/2012 | CN102702298A Glycyrrhetinic acid derivative and preparation method and medical application thereof |
10/03/2012 | CN102702288A Method for glycosylation of flavonoid compounds |
10/03/2012 | CN102702277A Compound of single sugar cluster and heterozygous sugar cluster, preparation method and applications thereof |
10/03/2012 | CN102702259A Pyrazol methyl amino phosphonate compound, preparation and application thereof in resisting cancer |
10/03/2012 | CN102702245A Hydrophobic mesoporous nanomaterial and preparation method and application thereof |
10/03/2012 | CN102702221A Xyloketal B analogue as well as preparation method and application thereof |
10/03/2012 | CN102702215A Compound mangostenone F, preparation method and application in preparation of antitumor drugs thereof |
10/03/2012 | CN102702212A N-(2-subtituted acyl) pyrazol derritol and application thereof as medicament |
10/03/2012 | CN102702210A Application of phthalocyanine metal complex containing piperazine ethyoxyl modified groups |
10/03/2012 | CN102702200A (6RS)-5-methyl tetrahydrofolate calcium salt crystal form and preparation process thereof |
10/03/2012 | CN102702194A Anti-viral compounds |
10/03/2012 | CN102702193A Anti-viral compounds |
10/03/2012 | CN102702187A New crystal form of penehyclidine hydrochloride and preparation method of new crystal form |
10/03/2012 | CN102702184A Novel oxazolidinone derivatives |
10/03/2012 | CN102702182A Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders |
10/03/2012 | CN102702179A 4-(3-chloro-4-methoxylanilino)-6-(furan-2-radical)quinazoline compound or pharmaceutically-acceptable salt thereof and preparation methods and applications thereof |
10/03/2012 | CN102702178A Process for the preparation of lapatinib and the salts thereof |
10/03/2012 | CN102702171A Process for producing acid adduct salt of polyacidic base compound |
10/03/2012 | CN102702164A Human ATP-binding cassette transporter A1 activity regulator screening model and application thereof |
10/03/2012 | CN102702156A Pinocembrin alpha crystal form and preparation method and use in disease treatment thereof |
10/03/2012 | CN102702155A Scutellarin aglycone methylate product based on in-vivo metabolic mechanism as well as preparation method and application of scutellarin aglycone methylate product |
10/03/2012 | CN102702147A Andrographolide analogue and application of andrographolide analogue to treatment |
10/03/2012 | CN102702140A Preparation method and application of water-soluble paclitaxel compound |
10/03/2012 | CN102702134A Thiazolidone derivative and application thereof to preparation anti-lung-cancer medicament |
10/03/2012 | CN102702126A Compound for anesthetics |
10/03/2012 | CN102702121A New compound m-hydroxyphenyl tetrazine dicarbonamide, preparation and application thereof |
10/03/2012 | CN102702120A New compound o-hydroxyphenyl tetrazine dicarbonamide, preparation and application thereof |
10/03/2012 | CN102702119A Pharmaceutical combinations of an angiotensin receptor antagonist and an NEP inhibitor |
10/03/2012 | CN102702118A Valsartan organic pharmaceutical co-crystal and preparation method thereof |
10/03/2012 | CN102702116A 4-(3-chloro-4-methoxylanilino)-6-(3-amidophenyl)quinazoline compound or pharmaceutically-acceptable salt thereof and preparation methods and applications thereof |
10/03/2012 | CN102702111A Processes for the preparation of 4-((4-((4-(2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)benzonitrile |
10/03/2012 | CN102702109A Benzenesulfonamide compound and application thereof |
10/03/2012 | CN102702092A Eutectic of two curcumin organic medicaments and preparation method thereof |
10/03/2012 | CN102702071A New compound in henbane and preparation method and application thereof |
10/03/2012 | CN102702070A Solid form containing (+)-2-[1-(3-oxethyl-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, composition and application thereof |
10/03/2012 | CN102702068A 3-pyrrolo-cyclohexylidene-2-dihydroindolone derivative, and application of 3-pyrrolo-cyclohexylidene-2-dihydroindolone derivative |
10/03/2012 | CN102702057A Sulfonamide compound and uses thereof |
10/03/2012 | CN102702052A Novel diamine-containing farnesyl thiosalicylic acid derivative and preparation method and medicinal application thereof |
10/03/2012 | CN102702044A Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors |
10/03/2012 | CN102702041A Agomelatine benzenesulfonic acid compound and preparation method thereof |
10/03/2012 | CN102702033A Amorphous peramivir, preparation method thereof and medicinal composition |
10/03/2012 | CN102702013A Nuclear receptor binding agents |
10/03/2012 | CN102702008A Agomelatine sulfuric acid composition and preparation method thereof |
10/03/2012 | CN102702001A Stable amorphous ambroxol hydrochloride compound |
10/03/2012 | CN102701992A Anti-tumour compound, pharmaceutically accepted salts as well as preparation method and application thereof |
10/03/2012 | CN102698358A Preparation method for disposable compound iodine medical disinfecting large cotton bar |
10/03/2012 | CN102698294A Chitosan-supported hydroxycamptothecine-quantum dot FRET (Fluorescence Resonance Energy Transfer) composite probe |
10/03/2012 | CN102698286A Supramolecule assembly of targeting-delivery anticancer adamplatin and preparation of supramolecule assembly |